Abstract: The prevent disclosure provides a method and apparatus for adjusting a perspective of a direction indicator, an electronic device, and a storage medium, which includes that: a first area and a second area corresponding to a first direction indicator are acquired, where the first direction indicator is configured to indicate a forward direction in a panorama display scene, the first area is a visible area of the first direction indicator in a graphical user interface, and the second area is an invisible area of the first direction indicator outside the graphical user interface; an initial perspective range corresponding to the second area is acquired; a target perspective range to which a first perspective belongs is determined from the initial perspective range, and a second direction indicator corresponding to the target perspective range is displayed; and the first perspective is adjusted to a second perspective based on the second direction indicator.

Abstract: The present invention belongs to the technical field of PECVD devices. Disclosed are a drooping cover plate and a PECVD device having the drooping cover plate. In the drooping cover plate of the present invention, a first insulating frame is arranged on a bottom plate frame, and a second insulating frame is arranged on the first insulating frame; the bottom plate frame is formed of several bottom plates connected to each other, a lower side face of each bottom plate is provided with an extension portion that is perpendicular to the lower side face of the bottom plate; the first insulating frame is formed of several first insulating plates joined together, and the second insulating frame is formed of several second insulating plates joined together; and several strip-shaped holes communicating an inner side and an outer side of the bottom plate frame are formed.

Abstract: A use of alanyl-glutamine in preparation for a drug for treating, relieving or alleviating ocular surface diseases and/or conditions of non-dry eyes. A use of alanyl-glutamine in preparation for a drug for relieving or alleviating visual fatigue. A use of alanyl-glutamine in preparation for a beauty product and health-care product for relieving or alleviating asthenopia.

Abstract: A P2X3 and/or P2X2/3 receptor antagonist of formula (I), a pharmaceutical composition comprising the same, and a use thereof in preparing a drug for preventing or treating a disease mediated by the P2X3 and/or P2X2/3 receptor antagonist.

Abstract: An efficient microwave-assisted preparation method with one-step simultaneous reduction/embedding of a metal monatomic-doped reduced graphene oxide dielectric material. A metal salt aqueous solution is added to a graphene oxide aqueous dispersion to obtain a mixed dispersion. The mixed dispersion is mechanically stirred, such that the metal salt fully interacts with the graphene oxide, and the metal ions are uniformly loaded on a surface of the graphene oxide sheets through the interaction between metal ions and the oxygen-containing functional groups of the graphene oxide. The mixed dispersion is freeze-dried to obtain a metal salt/graphene oxide complex, which is subjected to a microwave treatment in the presence of an initiator in a microwave oven to allow reduction to obtain the metal monatomic-doped reduced graphene oxide dielectric material. An application of the metal monatomic-doped reduced graphene oxide dielectric material is also provided.

Abstract: An efficient microwave-assisted preparation method with one-step simultaneous reduction/embedding of a metal monatomic-doped reduced graphene oxide dielectric material. A metal salt aqueous solution is added to a graphene oxide aqueous dispersion to obtain a mixed dispersion. The mixed dispersion is mechanically stirred, such that the metal salt fully interacts with the graphene oxide, and the metal ions are uniformly loaded on a surface of the graphene oxide sheets through the interaction between metal ions and the oxygen-containing functional groups of the graphene oxide. The mixed dispersion is freeze-dried to obtain a metal salt/graphene oxide complex, which is subjected to a microwave treatment in the presence of an initiator in a microwave oven to allow reduction to obtain the metal monatomic-doped reduced graphene oxide dielectric material. An application of the metal monatomic-doped reduced graphene oxide dielectric material is also provided.

Abstract: The present invention relates to the field of biomedicine, particularly to double-stranded RNA molecules targeting CKIP-1 and uses thereof, particularly to use of the double-stranded RNA molecules for the treatment of inflammatory diseases such as arthritis, particularly rheumatoid arthritis.

Abstract: The present application relates to a pregabalin sustained release composition, comprising: (a) an active ingredient; (b) a matrix-forming agent; (c) a swelling agent; (d) a gelling agent; and optionally a filler. The pregabalin sustained release composition provided in the present application can rapidly swell in volume when exposed to aqueous medium until exceeding the dimeter of human gastric pyloric (13 mm). It thereby prolongs the gastric emptying time to increase the retention time of pregabalin in the stomach and enhances absorption of pregabalin in the small intestine and ascending colon. Moreover, the pregabalin sustained release composition provided herein achieves a sustained release for 24 h, which allows QD (once a day) administration, reduces administration number, and improves patient compliance.

Abstract: The present invention provides a supported metal catalyst with synergistic sites, a preparation method therefor and an application thereof. The preparation method of this catalyst is to utilize the unsaturated cubane-like structure, M cation with catalytic activity is introduced into the cluster core unit. By using the vertex vacancy as the capturing center, and adjusting the impregnation temperature to maximize the loading of the cluster precursor, as well as depending on the electrostatic adsorption of the support and the confinement of the cluster structural unit, the number of S vacancies and the distance between S vacancies and Miso sites are effectively controlled through liquid phase reduction and atmosphere treatment at room temperature to obtain supported X3MSx/Al2O3 catalyst with Miso-Vs synergistic sites.

Abstract: A P2X3 and/or P2X2/3 receptor antagonist of formula (I), a pharmaceutical composition comprising the same, and a use thereof in preparing a drug for preventing or treating a disease mediated by the P2X3 and/or P2X2/3 receptor antagonist.

Abstract: The present invention discloses a receptor inhibitor of formula (I), a composition comprising the same and the usage thereof.

Abstract: The present invention discloses a hollow spherical catalyst for a fixed bed with internal fluidization of particles and a method for preparing the same. The preparation method used in the present invention is characterized in: fully mixing precious metal nanopowder with an organic oil phase to form an internal oil phase; preparing a gel ball of an oil-in-water structure by taking an aluminum oxide molding solution as an outer aqueous phase using an independently researched and developed coaxial dual-dropper forming apparatus; and then preparing a hollow aluminum oxide catalyst containing precious metal powder from the gel ball through processes of aging, calcination, and reduction. The resulting catalyst is expressed as X@Al2O3, where the precious metal nanopowder X is wrapped inside hollow Al2O3, and the catalyst has an outer diameter of 1.5-5.0 mm, a shell pore diameter (aluminum oxide) of 10-50 nm, and the precious metal nanopowder sized 200-500 nm.

Abstract: The prevent disclosure provides a method and apparatus for adjusting a perspective of a direction indicator, an electronic device, and a storage medium, which includes that: a first area and a second area corresponding to a first direction indicator are acquired, where the first direction indicator is configured to indicate a forward direction in a panorama display scene, the first area is a visible area of the first direction indicator in a graphical user interface, and the second area is an invisible area of the first direction indicator outside the graphical user interface; an initial perspective range corresponding to the second area is acquired; a target perspective range to which a first perspective belongs is determined from the initial perspective range, and a second direction indicator corresponding to the target perspective range is displayed; and the first perspective is adjusted to a second perspective based on the second direction indicator.

Abstract: Provided are compounds represented by general formula (I), which can be used for treating ATR kinase-mediated diseases, such as proliferative diseases, such as cancer. Further provided are a pharmaceutical composition of the compound represented by general formula (I), a use thereof in treating ATR kinase-mediated diseases, and a preparation thereof.

Abstract: Cuy/MMgOx interfacial catalyst for selective alkyne hydrogenation and its preparation method are disclosed. The preparation method of the catalyst includes: the mixture of salt and alkali solution is nucleated momentarily by nucleation/crystallization isolation method, preparing the composite metal hydroxide CuyMMg4-LDHs as precursor, which has typical hexagonal morphology of the double hydroxide; the precursor is topologically transformed by heat treatment to produce unsaturated oxide; the catalyst with Cuy-MMgOx interface structure is prepared by separating and electronically modifying Cu particles. By adjusting the ratio of Cu2+/M3+ in LDHs, the electronic and geometric structure of Cuy-MMgOx interface can be flexibly controlled, thus enhancing the reaction activity, product selectivity and stability. The catalyst can be used in the selective hydrogenation of various alkynes in the fields of petrochemical and fine chemical industry, with the outstanding catalytic activity and C?C double bond selectivity.

Abstract: The present invention discloses a catalyst for in-situ CO2 capture and coupling reduction with biomass oxidation, a preparation method therefor and an application thereof. The catalyst is applied to the coupling reaction of photocatalytic CO2 reduction and biomass oxidation. The preparation of the catalyst is to synthesize layered double hydroxides (LDHs) containing CO32? between layers by using coprecipitation method, hydrothermal method, sol-gel method and the like, wherein the chemical formula is [M1-x2+Mx3+(OH)2]x+(An?)x/n·mH2O, which has a thickness of 20-30 nm and an average particle diameter of 60-90 nm. Then metal ion vacancy defects are produced on LDHs laminate by using a NaOH/KOH selective etching to obtain the corresponding catalyst.